Bio-Rad (BIO) Q4 Earnings Beat, Revenues Miss, Margins Down

Bio-Rad Laboratories, Inc. (BIO) posted fourth-quarter 2023 adjusted earnings per share (EPS) of $3.10, beating the Zacks Consensus Estimate by 5.8%. However, the bottom line declined 6.3% from the prior-year quarter’s levels.The quarter’s adjustments eliminate the impacts of certain non-recurring items like the amortization of purchased intangibles, Restructuring costs, gains/losses from the change in the fair market value of equity securities and gains/losses on equity-method investments.The company’s GAA ...